| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -3.29M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, APRE returned -61.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -25.0% |
| 1 year | -61.1% |
| 5 years | -99.3% |
| All-time high | $917.80 (Dec 2019) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in APRE would be worth today ›No. Aprea Therapeutics, Inc. has not paid a dividend in the past 12 months.
Aprea Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol APRE.
Aprea Therapeutics, Inc. is part of the Healthcare sector.
Aprea Therapeutics, Inc. has a market cap of 8.06M USD, based on the latest quote.
